Avenue Therapeutics, Inc. ( ATXI) - Stock Earnings
ATXI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -683000 USD | — USD |
| 2025Q4 | -709000 USD | — USD |
| 2026Q1 | -695000 USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ATXI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.4 million USD | — USD |
| 2024 | -11.7 million USD | — USD |
| 2025 | -2.9 million USD | 1.4 million USD |
| 2026 Est. | — | — |
ATXI
Price: $0.33
52 week price:
Earnings Per Share: -0.52 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 246300
Market Capitalization: 1.2 million